Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.95
Bid: 2.90
Ask: 3.00
Change: 0.00 (0.00%)
Spread: 0.10 (3.448%)
Open: 2.95
High: 2.95
Low: 2.95
Prev. Close: 2.95
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Jan 2018 15:30

RNS Number : 7057C
ValiRx PLC
23 January 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

ValiRx PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

YA II CD, Ltd.

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

Jarvis Investment Management Ltd

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

18 January 2018

6. Date on which issuer notified (DD/MM/YYYY):

19 January 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.32%

5.32%

407,462,717

Position of previous notification (if

applicable)

6.99%

6.99%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares (GB00BWWYSP41)

21,680,526

0

5.32%

0

SUBTOTAL 8. A

21,680,526

5.32%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Yorkville Advisors Global II, LLC

5.32%

5.32%

Yorkville Advisors Global, LP

5.32%

5.32%

YA II CD, Ltd.

5.32%

5.32%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

The Ordinary Shares are held by Jarvis Investment Management in CREST for the benefit of YA II CD, Ltd.

 

 

Place of completion

Mountainside, New Jersey, USA

Date of completion

19 January 2018

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOUVRWKAAUAR
Date   Source Headline
25th Jun 20137:00 amRNSInvestor Presentation in Manchester
18th Jun 20134:11 pmRNSManchester One2One Investors Forum - June 26
13th Jun 20137:00 amRNSRe: VAL201 Update
6th Jun 201310:00 amRNSValiRx admitted as founder member of the SSE
25th Apr 20137:00 amRNSNew Patent Granted
22nd Apr 201311:52 amRNSResult of AGM
2nd Apr 20137:00 amRNSUpdate on Developmental and Clinical Activity
28th Mar 20137:01 amRNSFinal Results
21st Feb 20137:00 amRNSRe Commercial Development Update
23rd Jan 20137:00 amRNSAppointment of Medical Monitoring Officer
31st Dec 20127:00 amRNSTotal Voting Rights
22nd Nov 20127:00 amRNSRe: Update
19th Nov 201212:19 pmRNSResult of General Meeting
1st Nov 20121:49 pmRNSPlacing and Notice of General Meeting
11th Oct 20127:00 amRNSre: UK Distribution Agreement
20th Sep 20127:00 amRNSHalf Yearly Report
6th Sep 20127:00 amRNSVAL201 Update re: Breast Cancer Study
2nd Aug 20127:00 amRNSRe: GeneICE and Biomarkers Development Update
29th May 201211:07 amRNSResult of AGM
29th May 20127:00 amRNSUpdate re: Late Pre-clinical Study of VAL201
15th May 20127:00 amRNSNew US Patent Grant
27th Apr 20127:00 amRNSFinal Results
2nd Apr 201212:17 pmRNSDirector/PDMR Shareholding
2nd Apr 20127:00 amRNSPlacing of GBP 900,000 and Director's Dealing
29th Mar 20127:00 amRNSRe Agreement
8th Mar 20127:00 amRNSPeer Review Findings Published re VAL201
14th Feb 20127:00 amRNSEstablishment of Scientific & Advisory Board
2nd Feb 20127:00 amRNSNew European Patent Grant
31st Jan 201210:14 amRNSTotal Voting Rights
5th Jan 20127:00 amRNSAcquisition
15th Dec 20117:00 amRNSNew Patent Grant for GeneICE & VAL101 Update
9th Dec 20114:23 pmRNSRe Volition - Allotment of Shares
24th Nov 20117:00 amRNSHolding(s) in Company
3rd Nov 20117:00 amRNSNew Patent Filing
7th Oct 20118:00 amRNSVolition Update
27th Sep 20117:00 amRNSVolition Update
22nd Sep 20117:00 amRNSHalf Yearly Report
8th Sep 20117:00 amRNSDistribution Agreement
18th Aug 20117:00 amRNSAcquisition of Finnish Non-Trading Company
28th Jul 20117:00 amRNSVAL201 Update
19th Jul 20113:59 pmRNSHolding(s) in Company
14th Jul 20117:00 amRNSDirector/PDMR Shareholding
11th Jul 20117:00 amRNSGrant of Options
23rd Jun 201110:55 amRNSResult of AGM
23rd Jun 20117:00 amRNSAGM Statement
21st Jun 20117:00 amRNSGeneICE Update
10th Jun 20117:00 amRNSVolition - update
2nd Jun 20117:00 amRNSDirectorate Change
31st May 20111:30 pmRNSPublication of Report & Accounts and Notice of AGM
31st May 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.